Serina Therapeutics logo
Serina Therapeutics
SER | AMEX
Chart Builder DCF Calculator
$1.42
+$0.03 (+2.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.48
+$0.06 (+4.23%)
After-hours: Nov 16, 2026, 7:00 PM ET

Serina Therapeutics Company Profile

Company profile explained

Company Profile

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.

Key Executives

Name Position
Steven A. Ledger Chief Executive Officer & Director
Gregory S. Curhan Chief Financial Officer
Balkrishan Gill Executive Co-Chairman of the Board
J. Milton Harris Co-Founder, Director Emeritus & Chair of Scientific Advisory Board
Joshua Thomas Head of Chemistry
Randall W. Moreadith Chief Development Officer
Srini Tenjarla Chief Technical Operations Officer

Latest SEC Filings

Date Type Title
Oct 09, 2026 8-K Current Report
Sep 09, 2026 8-K Current Report
Aug 31, 2026 EFFECT Filing
Aug 27, 2026 8-K Current Report
Aug 24, 2026 S-1 Filing
Aug 13, 2026 S-8 Filing
Aug 13, 2026 8-K Current Report
Aug 13, 2026 10-Q Quarterly Report
Jul 23, 2026 4 Filing
Jul 23, 2026 3 Filing
View All SEC Filings ➞
Serina Therapeutics
Serina Therapeutics logo
Country United States
IPO Date Nov 28, 2018
Industry Biotechnology
Sector Healthcare
Employees 16
CEO Steven A. Ledger

Contact Details

601 Genome Way Huntsville, Alabama 35806 United States

Stock Details

Ticker Symbol SER
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001708599
CUSIP Number 81751A108
ISIN Number US81751A1088
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.